Magic mushrooms tested for depression in veterans with spinal injuries

NCT ID NCT07251491

First seen Jun 25, 2026 · Last updated Aug 11, 2026 · Updated 4 times

Summary

This study tests whether psilocybin (the active ingredient in magic mushrooms) is safe and tolerable for veterans with spinal cord injury who also have depression. Thirty participants will receive low, medium, or high doses and be monitored for side effects like pain, muscle spasms, and blood pressure changes. The study also tracks how well the psychedelic experience is tolerated and any changes in depression symptoms.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Psilocybin (magic mushrooms)
What this could lead to
If it works, this could point toward a new treatment option for depression in people with spinal cord injury.
What could go wrong
This is an early-phase trial with only 30 participants, so results may not apply broadly. Psilocybin can cause intense psychological effects and temporary increases in blood pressure or anxiety.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION - MAJOR DEPRESSIVE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • James J. Peters Department of Veterans Affairs Medical Center

    RECRUITING

    The Bronx, New York, 10468, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.